This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Dong Wha Pharmaceutical Co. Ltd.. Active years: 2010-2012.
Company Filing History:
Years Active: 2010-2012
Title: Do-Hui Kim: Innovator in Osteoporosis Treatment
Introduction
Do-Hui Kim is a notable inventor based in Songnam-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of osteoporosis. With a total of 3 patents to his name, Kim's work is recognized for its innovative approach to addressing bone health.
Latest Patents
Among his latest patents, Kim has developed a pharmaceutical composition that utilizes 4-[(4-thiazolyl)phenoxy]alkoxy-benzamidine derivatives for the prophylaxis and treatment of osteoporosis. This invention specifically focuses on the use of compounds such as 4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy}-benzamidine. The composition aims to provide effective treatment options for individuals suffering from osteoporosis by inhibiting osteoclast activity and stimulating osteoblast activity.
Career Highlights
Do-Hui Kim is currently employed at Dong Wha Pharmaceutical Co. Ltd., where he continues to advance his research and development efforts. His work has garnered attention in the pharmaceutical industry, contributing to innovative solutions for bone health.
Collaborations
Kim collaborates with esteemed colleagues, including Hong-Suk Suh and Pan-Soo Kim, who contribute to his research endeavors. Their combined expertise enhances the development of effective treatments in the field of osteoporosis.
Conclusion
Do-Hui Kim's contributions to osteoporosis treatment through his innovative patents highlight his role as a significant inventor in the pharmaceutical industry. His ongoing work promises to improve the quality of life for many individuals affected by this condition.